RTT
These include the identification of many MeCP2 target genes, better understanding of the neurobiological consequences of the loss- or mis-function of MeCP2, and drug testing in RTT mice and clinical trials in human RTT patients.
These include the identification of many <span class="gene" id="21966470-3-41-46">MeCP2</span> target genes, better understanding of the neurobiological consequences of the loss- or mis-function of <span class="gene" id="21966470-3-150-155">MeCP2</span>, and drug testing in <span class="disease" id="21966470-3-177-180">RTT</span> mice and clinical trials in human <span class="disease" id="21966470-3-215-218">RTT</span> patients.